{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:54:57Z","timestamp":1781672097930,"version":"3.54.5"},"reference-count":16,"publisher":"Norwegian Medical Association","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"published-print":{"date-parts":[[2009,12,17]]},"DOI":"10.4045\/tidsskr.09.0982","type":"journal-article","created":{"date-parts":[[2009,11,23]],"date-time":"2009-11-23T06:52:27Z","timestamp":1258959147000},"page":"2610-2","source":"Crossref","is-referenced-by-count":2,"title":["M\u00e5 penicillin tas utenom m\u00e5ltider?"],"prefix":"10.4045","volume":"129","author":[{"given":"Andreas Austgulen","family":"Westin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf A.","family":"Walstad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7902-9014","authenticated-orcid":false,"given":"Olav","family":"Spigset","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","reference":[{"key":"ref=1","unstructured":"Amsden GW, Ballow CH, Bertino JS jr. et al. Pharmacokinetics and pharmacodynamics of anti-infective agents. I: Mandrell GL, Bennett H, Dolin R, red. Principles and practice of infectious diseases. 6 utg. Baltimore, MD: Churchill Livingstone, 2005: 271\u201381."},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"Schentag JJ, Gilliland KK, Paladino JA. What have\u00a0we learned from pharmacokinetic and pharmacodynamic theories? Clin Infect Dis 2001; 32 (suppl\u00a01): S39\u201346.","DOI":"10.1086\/319375"},{"key":"ref=3","unstructured":"H\u00f8iby EA, Walstad RA. Vi b\u00f8r bli bedre til \u00e5 dosere antibiotika. Tidsskr Nor Legeforen 2008; 23: 2750."},{"key":"ref=4","unstructured":"Chambers HF. Penicillins. I: Mandrell GL, Bennett JL, Dolin R, red. Principles and practice of infectious diseases. 6 utg. Baltimore, MD: Churchill Livingstone, 2005: 281\u201393."},{"key":"ref=5","unstructured":"Ericson S. Fenoksymetylpenicillinpr\u00e6parater. En dobbelt-blind overkrydsningsunders\u00f8gelse. Ugeskr L\u00e6ger 1977; 139: 2740\u20132."},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Rollag H jr., Midtvedt T, Wetterhus S. Serum levels of penicillin V after oral administration of pediatric preparations to healthy subjects. Acta Paediatr Scand 1975; 64: 421\u20134.","DOI":"10.1111\/j.1651-2227.1975.tb03858.x"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Bergan T, Berdal BP, Holm V. Relative bioavailability of phenoxymethylpenicillin preparations in a cross-over study. Acta Pharmacol Toxicol (Copenh) 1976; 38: 308\u201320.","DOI":"10.1111\/j.1600-0773.1976.tb03125.x"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Josefsson K, Magni L. Absorption of phenoxymethylpenicillin from mixtures and tablets in healthy volunteers. J Int Med Res 1983; 11: 380\u20134.","DOI":"10.1177\/030006058301100611"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"Moreno RA, Boldrina L, Guermani A et al. Comparative bioavailability study of two phenoxymethylpenicillin potassium tablet formulations in\u00a0healthy volunteers. Int J Clin Pharmacol Ther 2007; 45: 669\u201376.","DOI":"10.5414\/CPP45669"},{"key":"ref=10","unstructured":"Amsden GW. Tables of antimicrobial agent pharmacology. I: Mandrell GL, Bennett JL, Dolin R, red. Principles and practice of infectious diseases. 6 utg. Baltimore, MD: Churchill Livingstone, 2005: 634\u2013700."},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"McCarthy CG, Hirsch HA, Finland M. Serum levels after single oral doses of 6-(a-phenoxypropionamido) penicillanate and penicllin V. Proc Soc Exp Biol Med 1960; 103: 117\u201380.","DOI":"10.3181\/00379727-103-25450"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"Cronk GA, Wheatley WB, Fellers GF et al. The relationship of food intake to the absorption of potassium alpha-phenoxyethyl penicillin and potassium phenoxymethyl penicillin from the gastrointestinal tract. Am J Med Sci 1960; 240: 219\u201325.","DOI":"10.1097\/00000441-196008000-00010"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"Finkel Y, Bolme P, Eriksson M. The effect of food on the oral absorption of penicillin V preparations in children. Acta Pharmacol Toxicol (Copenh) 1981; 49: 301\u20134.","DOI":"10.1111\/j.1600-0773.1981.tb00910.x"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"Roos K, Brorson JE. Concentration of phenoxymethylpenicillin in tonsillar tissue. Eur J Clin Pharmacol 1990; 39: 417\u20138.","DOI":"10.1007\/BF00315423"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"Ekedahl C, Holm SE, Jeppsson PH et al. Concentration of phenoxymethylpenicillin (pcV) in the mucous membrane of maxillary sinus in patients with and without sign of sinusitis. Acta Otolaryngol 1981; 92: 371\u20137.","DOI":"10.3109\/00016488109133274"},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"Sj\u00f6blom AC, Bruchfeld J, Eriksson B et al. Skin concentrations of phenoxymethylpenicillin in patients with erysipelas. Infection 1992; 20: 30\u20133.","DOI":"10.1007\/BF01704891"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":[],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:27:31Z","timestamp":1781670451000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2009\/12\/legemidler-i-praksis\/ma-penicillin-tas-utenom-maltider"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,17]]},"references-count":16,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2009,12,17]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.09.0982","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,17]]}}}